Trending...
- Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
- Mecpow M1: A Safe & Affordable Laser Engraver Built for Home DIY Beginners
- Postmortem Pathology Expands Independent Autopsy Services Across Colorado
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Unilever PLC ("Unilever" or the "Company") (NYSE: UL) American Depositary Receipts ("ADRs") between September 2, 2020 and July 21, 2021, inclusive (the "Class Period"). Unilever investors have until August 15, 2022 to file a lead plaintiff motion.
Investors suffering losses on their Unilever investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On July 19, 2021, Unilever's subsidiary ice cream company, Ben & Jerry's announced that, upon the expiration of the current licensing agreement by which its products had been distributed in Israel for decades, it would end sales of its ice cream in "Occupied Palestinian Territory" but would purportedly continue to sell its products in Israel. On this news, the Company's ADR price fell $0.58 per ADR, or 1%.
More on The PennZone
Then, on July 22, 2021, CNBC reported that Texas and Florida were examining Ben & Jerry's actions in connection with their legislation against the boycott, divestment, and sanctions ("BDS") movement, a controversial movement whose objective is to coerce Israel into making concessions to the Palestinians. In a letter from the state of Florida's CFO Jimmy Patronis, who controls Florida's public pension funds, Florida would "be prohibited from investing in Ben & Jerry's or its parent company, Unilever." That also meant that Unilever could not enter or renew contracts with the state or any municipality in Florida.
On this news, Unilever's ADR price fell $3.08, or 5.4%, to close at $53.45 per ADR on July 22, 2021, thereby injuring investors further.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that, in July 2020, Ben & Jerry's board passed a resolution to end sales of its ice cream in "Occupied Palestinian Territory"; (2) the risks attendant to the Ben & Jerry's board's decision; (3) the foregoing risked adverse governmental actions for violations of laws, executive orders, or resolutions aimed at discouraging boycotts, divestment, and sanctions of Israel adopted by 35 U.S. states; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
More on The PennZone
If you purchased Unilever ADRs, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Investors suffering losses on their Unilever investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On July 19, 2021, Unilever's subsidiary ice cream company, Ben & Jerry's announced that, upon the expiration of the current licensing agreement by which its products had been distributed in Israel for decades, it would end sales of its ice cream in "Occupied Palestinian Territory" but would purportedly continue to sell its products in Israel. On this news, the Company's ADR price fell $0.58 per ADR, or 1%.
More on The PennZone
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
- TrueNorth Wellness Services is Excited to Participate in Give Local York
- March Is Skiing's Smartest Buying Window
Then, on July 22, 2021, CNBC reported that Texas and Florida were examining Ben & Jerry's actions in connection with their legislation against the boycott, divestment, and sanctions ("BDS") movement, a controversial movement whose objective is to coerce Israel into making concessions to the Palestinians. In a letter from the state of Florida's CFO Jimmy Patronis, who controls Florida's public pension funds, Florida would "be prohibited from investing in Ben & Jerry's or its parent company, Unilever." That also meant that Unilever could not enter or renew contracts with the state or any municipality in Florida.
On this news, Unilever's ADR price fell $3.08, or 5.4%, to close at $53.45 per ADR on July 22, 2021, thereby injuring investors further.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that, in July 2020, Ben & Jerry's board passed a resolution to end sales of its ice cream in "Occupied Palestinian Territory"; (2) the risks attendant to the Ben & Jerry's board's decision; (3) the foregoing risked adverse governmental actions for violations of laws, executive orders, or resolutions aimed at discouraging boycotts, divestment, and sanctions of Israel adopted by 35 U.S. states; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
More on The PennZone
- Hope Survives Launches The Hope Collective, A Curated Publication Centering Lived Experience After Brain Injury
- Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
- Tobu Group's "T-home Series" of Accommodations in Tokyo Just Opened "T-home KEI."
- Custom Wooden Token Manufacturer Celebrates 10 Years of Helping Brands Stay Top of Mind
- NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
If you purchased Unilever ADRs, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com
Filed Under: Business
0 Comments
Latest on The PennZone
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract
- Cancun All Inclusive is ready for Spring Break 2026 with new Resorts, Exclusive Deals, activities and more!
- 66% of US Bankruptcies Are Medical — So Americans Are Building Businesses That Cover Healthcare Emergencies
- Ludex Partners With Certified Trading Card Association (CTCA) To Elevate Standards And Innovation In The Trading Card Industry
- Best Book Publishing Company for Aspiring Authors
- Dr. Nadene Rose Releases Moving Memoir on Faith, Grief, and Divine Presence
- Gigasoft Solves AI's Biggest Charting Code Problem: Hallucinated Property Names
- ASTI Ignites the Space Economy: Powering SpaceX's NOVI AI Pathfinder with Breakthrough Solar Technology: Ascent Solar Technologies (N A S D A Q: ASTI)
- Hiring has reached a "Digital Stalemate"—Now, an ex-Google recruiter is giving candidates the answers
- 2026 Pre-Season Testing Confirms a Two-Tier Grid as Energy Management Defines Formula 1's New Era
- The Philadelphia Party Launches to Expand Civic Leadership, Candidate Pathways, and Education
- Platinum Car Audio LLC Focuses on Customer-Driven Vehicle Audio and Electronics Solutions
- Postmortem Pathology Expands Independent Autopsy Services in Kansas City
- Postmortem Pathology Expands Independent Autopsy Services Across Colorado